We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-0.95%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$55.7B
AUM Growth
+$1.33B
Cap. Flow
+$2.27B
Cap. Flow %
4.08%
Top 10 Hldgs %
19.71%
Holding
3,688
New
269
Increased
1,855
Reduced
1,236
Closed
227

Sector Composition

Rank Sector Weight
1 Technology 10.05%
2 Financials 9.3%
3 Healthcare 7.74%
4 Industrials 6.94%
5 Communication Services 5.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GGP
2726
DELISTED
GGP Inc.
GGP
$376K ﹤0.01%
18,359
+5,042
+38% +$112K
REET icon
2727
iShares Global REIT ETF
REET
$5.01B
$375K ﹤0.01%
15,272
-27,064
-64% -$671K
PLOW icon
2728
Douglas Dynamics
PLOW
$979M
$374K ﹤0.01%
8,618
-1,146
-12% -$47.5K
ZG icon
2729
Zillow
ZG
$7.71B
$374K ﹤0.01%
+6,929
New +$334K
BMI icon
2730
Badger Meter
BMI
$3.93B
$373K ﹤0.01%
7,909
+1,120
+16% +$54.2K
MFG icon
2731
Mizuho Financial
MFG
$127B
$373K ﹤0.01%
100,720
+9,739
+11% +$36.7K
TSI
2732
TCW Strategic Income Fund
TSI
$213M
$373K ﹤0.01%
67,052
-3,000
-4% -$16.5K
WLKP icon
2733
Westlake Chemical Partners
WLKP
$760M
$373K ﹤0.01%
16,683
+770
+5% +$18.1K
MRT
2734
DELISTED
MedEquities Realty Trust, Inc.
MRT
$373K ﹤0.01%
35,518
+10,251
+41% +$109K
MWA icon
2735
Mueller Water Products
MWA
$4.09B
$371K ﹤0.01%
34,118
-84,438
-71% -$972K
XLRN
2736
DELISTED
Acceleron Pharma
XLRN
$371K ﹤0.01%
9,478
+164
+2% +$6.97K
GOVI icon
2737
Invesco Equal Weight 0-30 Year Treasury ETF
GOVI
$1.22B
$370K ﹤0.01%
11,625
-1,849
-14% -$58.7K
PBJ icon
2738
Invesco Food & Beverage ETF
PBJ
$107M
$370K ﹤0.01%
11,487
-2,673
-19% -$88.5K
AKBA icon
2739
Akebia Therapeutics
AKBA
$240M
$369K ﹤0.01%
38,761
-798
-2% -$11.2K
SE icon
2740
Sea Limited
SE
$80.5B
$369K ﹤0.01%
32,767
+5,323
+19% +$63.6K
BFZ
2741
DELISTED
BlackRock CA Municipal Income Trust
BFZ
$368K ﹤0.01%
28,315
-9,091
-24% -$121K
TBT icon
2742
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$308M
$368K ﹤0.01%
10,156
-1,250
-11% -$46.4K
LGCY
2743
DELISTED
Legacy Reserves Inc. Common Stock
LGCY
$368K ﹤0.01%
78,060
+23,627
+43% +$70.1K
MCHP icon
2744
CALL
Microchip Technology
MCHP
$44B
$366K ﹤0.01%
280,000
-38,200
-12% -$1.76M
MLPX icon
2745
Global X MLP & Energy Infrastructure ETF
MLPX
$3.54B
$366K ﹤0.01%
10,355
-1,798
-15% -$70.7K
PRLB icon
2746
Protolabs
PRLB
$2.16B
$366K ﹤0.01%
3,115
+157
+5% +$17.7K
AFTY
2747
DELISTED
Pacer CSOP FTSE China A50 ETF
AFTY
$366K ﹤0.01%
20,605
+1,191
+6% +$22.4K
FRPH icon
2748
FRP Holdings
FRPH
$425M
$364K ﹤0.01%
+13,000
New +$330K
RL icon
2749
Ralph Lauren
RL
$23.7B
$364K ﹤0.01%
3,258
+84
+3% +$9.09K
IBML
2750
DELISTED
iShares iBonds Dec 2023 Term Muni Bond ETF
IBML
$364K ﹤0.01%
+14,622
New +$366K

Similar funds

Raymond James & Associates's Q1 2018 Portfolio in Review

As of Q1 2018, Raymond James & Associates held 3,688 positions worth $55.7B, up 2.4% from $54.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Raymond James & Associates deployed $2.27B of net new capital in Q1 2018, opening 269 new positions and adding to 1,855 existing holdings. Its largest new stake was Nutrien: 608,282 shares worth $28.7M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 9.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was AbbVie, an estimated $68.1M trimmed.

  • Raymond James & Associates's largest Q1 2018 buy was Nutrien: 608,282 shares worth $28.7M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q1 2018, an estimated $211M increase.
  • Raymond James & Associates's biggest Q1 2018 reduction was AbbVie, cutting an estimated $68.1M.
  • Raymond James & Associates fully exited Regal Entertainment Group in Q1 2018, selling an estimated $48.4M.
  • Raymond James & Associates's ten largest holdings make up 20% of its $55.7B portfolio in Q1 2018.
  • Raymond James & Associates opened 269 new positions and closed 227 in Q1 2018.
  • Raymond James & Associates's portfolio value rose 2.4% quarter-over-quarter to $55.7B.

Based on Raymond James & Associates's 13F filing for Q1 2018, filed 14 May 2018.